Mutations in ASXL1 and SETBP1 genes have been frequently detected and often coexist in a variety of myeloid neoplasms, including myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML)1–3. This evidence concerns the gene ASXL1 and acute myeloid leukemia.